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276a Monday, February 22, 2010water-soluble polymer, PEG, to the lamellar phase of DMPC or of several
surfactants, induces a topological transformation to a vesicular phase. Such tran-
sition can be understood in terms of amodification of the elastic properties of the
membranes. In this work we perform a dynamic light scattering (DLS) study of
the effect of PEG on phospholipid and surfactant bilayers. The experimental
results show that the addition of the polymer slows down the dynamics of the
membranes. From fits to an available theory for the scattering of dilute mem-
brane systems, we have calculated the bending elastic modulus of the bilayers.
This modulus increases with increasing polymer concentration, thus confirming
that the macromolecule modifies the elastic properties of the membranes.Membrane Active Peptides II
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Ribosomally synthesized antimicrobial peptides (AMPs) are conserved compo-
nents of the innate immunity of all life forms and represent the most ancient and
efficient weapon against microbial pathogens.
The emergence of multidrug-resistant microbes has urgently required the
discovery of new antibiotics with a new mode of action, and AMPs represent
promising candidates. Intense research focusing on AMPs is currently directed
to the elucidation of their mode(s) of action.
Nevertheless, very little is known about their effects on intact bacteria.
Here we report on Esculentin 1-18 [Esc(1-18)], a linear peptide covering the first
18 N-terminal residues of the full length amphibian peptide esculentin-1b.
Esc(1-18) retains the antimicrobial activity of esculentin-1b against awide range
of microorganims, with negligible effects on mammalian erythrocytes. To ex-
pand our knowledge on the molecular mechanism underlying the antimicrobial
activity onGram-negative bacteria, we investigated the effects of this peptide on
Escherichia coli, by studying its: i) structure in membrane mimicking environ-
ment; ii) killing kinetic; iii) bactericidal activity in different media; iv) ability to
permeate both artificial and bacterial membranes; v) capacity to synergize with
conventional antibiotics; vi) effect on cell morphology and proteome by means
of electron microscopy and proteomic techniques, respectively.
These studies have indicated that Esc(1-18) (i) kills E. coli via membrane-per-
turbation; (ii) elicits identical changes in the bacterium’s protein expression
pattern, at both lethal and sub-lethal concentrations; and (iii) preserves antibac-
terial activity under conditions closer to those encountered in vivo. This is in
contrast with many host defence peptides that kill microorganisms by altering
intracellular processes and lose activity in physiological solutions. Importantly,
to the best of our knowledge, this is the first case showing the effects of an
amphibian AMP on the protein expression profile of its bacterial target.
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Alamethicin is a 20-amino acid long antibiotic peptide produced by the fungus
Trichoderma viride. In the literature, alamethicin is the most commonly cited
example of a barrel-stave model pore-forming peptide. In this model, amphi-
pathic peptides form a long-lived transmembrane pore by aligning hydrophobic
and hydrophilic residues with the lipid bilayer and aqueous pore respectively. It
has been reported that voltage-independence of alamethicin pores relies on salt
and peptide concentrations. We have developed a set of fluorescence-based as-
says for leakage, stable pore formation and lipid flip-flop using large unilamel-
lar vesicles (LUVs) to help define the mechanism and potency of pore forming
peptides. An additional pre-incubation assay differentiates dynamic pores from
long-lived pores. When applied to alamethicin, our suite of assays show that,
at 2.0 mM peptide, alamethicin forms voltage-independent pores in anionic
or zwitterionic vesicles at peptide-to-lipid ratios as low as 1:2000. Less than
20 peptides per vesicle is sufficient to allow for complete vesicle permeabiliza-
tion. Even after overnight incubation with vesicles, alamethicin promotes
continuous lipid flip-flop, and is able to permeabilize multiple additions of
new vesicles. Other pore forming peptides tested at this P:L ratio do not pro-
mote continuous flip-flop and do not exchange into new vesicles. We postulate
that, unlike other pore-forming peptides, which mostly behave like classical
barrel-stave pores, alamethicin is in a continuous dynamic equilibrium between
transmembrane, interfacially bound and aqueous forms.1446-Pos
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Isolated from the venom sac of solitary spider wasp, Anoplius samariensis,
Anoplin is the smallest linear a-helical antimicrobial peptide found naturally
up to date. It has broad spectrum activity against both Gram-positive and
Gram-negative bacteria, and little hemolytic activity toward human erythro-
cytes (1,2). Previous studies showed that substitution of all amino acids in
the peptide with D-isomers can increase the bioavailability and reduce peptide
degradation without affecting the antimicrobial properties since the net charge
and the hydrophobicity are retained (3). In the present work, two stereoisomers
of Anoplin were studied using UV resonance Raman spectroscopy, Langmuir
Blodgett, atomic force microscopy, calcein leakage assay and antimicrobial
assay. UV resonance Raman data indicate that the two forms of the peptide
adopt similar conformations in aqueous buffer and in membrane mimicking
solutions. Monolayer isotherms show that D-Anoplin has a lightly greater area
per molecule than L-Anoplin. Finally, membrane rupturing ability of both ste-
reoisomers was found to depend strongly on membrane composition.
(1) Konno, K., Hisada, M., Fontana, R., Lorenzi, C.C.B., Naoki, H., Itagaki, Y.,
Miwa, A., Kawai, N., Nakata, Y., Yasuhara, T., Neto, J.R., deAzevedo Jr.,W.F.,
Palma, M.S. and Nakajima, T. (2001) Biochim. Biophys. Acta 1550: 70-80.
(2) Ifrah, D., Doisy, X., Ryge, R.S. and Hansen, P.R. (2005) J. Pept. Sci. 11:
113-121.
(3) Wade, D., Boman, A., Wahlin, B., Drain, C.M., Andreu, D., Boman, H.G.
and Merrifield, R.B. (1990) Proc. Nat. Acad. Sci. 87: 4761-4765.
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Antimicrobial peptides (AMPs) have received much attention as models for the
development of antibiotics capable of meeting the challenge of drug-resistant
infections. Our research has focused on a linear, 15-residue cecropin-mellitin
(CM) hybrid peptide designated CM15. In these studies we compare the bio-
logical activities and membrane interactions of CM15 and lysine substituted
derivates designed to have optimized amphipathicity upon membrane binding.
Previous studies have shown that these lysine enriched peptides maintain the
high antimicrobial activity of the parent peptide but have substantially decreased
hemolytic effects (Sato and Feix, Antimicrob. Agents Chemother. 52, 4463,
2008). Using model membranes to understand the differences that govern
peptide-membrane interaction, we have performed a series of biophysical exper-
iments including circular dichroism (CD), fluorescence, and site-directed spin
labeling (SDSL) electron paramagnetic resonance (EPR) spectroscopy. These
experiments establish the structures of themembrane-bound peptides, determine
the extent of membrane lysis, and allow determination of partition coefficients
and depth of penetration. Our results show that differences in red cell hemolysis
can be reconstructed using model membranes, and provide insights into the
mechanism ofmembrane disruption. This workwas supported by award number
R01GM068829 from the National Institute Of General Medical Sciences.
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Melittin is a 26 amino acid peptide that comprises more than half of the dry
weight of the venom of the honeybee Apis Mellifera. In previous studies, we
demonstrated that melittin stably bound to the lipid membrane of perfluorocar-
bon (PFC) nanoparticles and served as an active anti-cancer therapeutic agent
in vivo (Soman et al. J Clin Invest. 2009). Here, we report the structure modi-
fication that converts the mellittin to a cargo linker for post-formulation lipo-
some customization. We introduced point mutations and truncations to define
the lytic and membrane binding activities of melittin. For each of the mutations,
lytic activity of the peptides was tested by the carboxyfluorescein fluorescence
dequenching assay on carboxyfluorescein encapsulated liposomes. Among all
six melittin mutations, the mutation, D1-7, with the first 7 amino acids removed
(VLTTGLPALISWIKRKRQQ) dramatically reduces the melittin lytic activity.
Using immobilized Giant Unilamellar Vesicles (GUV), we illustrated that at
peptide:lipid ratio of 40:1, D1-7 bound to the GUVwithout pore forming, while
at peptide:lipid ratio of 1:83, melittin already formed pores on the GUV
Monday, February 22, 2010 277amembrane. These results suggest that D1-7 eliminates the lytic activity but re-
tains the strong lipid membrane binding. For further confirmation, we measured
liposome sizes and zeta potentials with and without D1-7 loading. Consistently,
D1-7 did not affect the size of the liposome, but shifted the zeta potential (or
surface charge) of the liposome towards the positive voltage range, because
D1-7 is a positively charged peptide. Among numerous existing nanosystems
for drug delivery, liposomes are approved by FDA for anti-cancer and gene
therapy. Accordingly, this linker and/or its refinements could enhance the
therapeutic potential of approved liposomal drugs by enabling flexible incorpo-
ration and cargo multiplexing through post-formulation surface editing.
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Increasingly prevalent resistance of pathogenic bacteria to conventional small-
molecule antibiotic drugs is creating an urgent need for the discovery of new
classes of antibiotics that are active against biofilms. Bacteria that are multidrug
resistant (MDR) are of increasing concern for infectious disease. Current treat-
ment of these infections that involve resistant organisms may require 6-12
months of antibiotic treatment, creating difficulties with compliance.
We are continuing to develop oligo-N-substituted glycine (peptoid) mimics of
cationic, helical antimicrobial peptides (AMPs), and some of our recently ac-
quired data indicate that peptoids could address the problem of growing resis-
tance. Peptoids have been shown to have extremely broad-spectrum activity,
and certain peptoids function well in the presence of serum proteins. Their
biophysical mechanism of action makes it difficult for bacteria to evolve resis-
tance to them. We have tested our most promising peptoids, peptides and com-
mercial antibiotics in vitro against bacterial biofilms of a variety of important
bacterial organisms. We show that certain peptoids can be as active as the pre-
ferred conventional antibiotics against bacterial infections, even at low micro-
molar doses. Small, structured biomimetic oligomers such as our antimicrobial
peptoids may offer a new class of drugs that are useful in treating persistent
bacterial infections.
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Antimicrobial peptides serve as one of the first lines of defense in the immune
systems of higher organisms. These peptides specifically target and neutralize
infecting bacteria in the host organism while exhibiting little or no toxic effect
on host cells. The peptide C18G is a highly cationic, amphiphilic peptide
derived from the C-terminal sequence of the human protein platelet factor 4
(involved in blood coagulation and wound repair) exhibited antibacterial activ-
ity against both gram positive and gram negative bacteria. Using a modified
C18G sequence that did not significantly affect antimicrobial efficacy (Tyr3
changed to Trp and all Lys changed to Arg (C18G Y3W K R)). The binding
affinity was measured with fluorescence spectroscopy using the W in the pep-
tide sequence as a probe of peptide environment. Small unilamellar lipid
vesicles were used to investigate the binding affinity of the peptide to bilayers
composed of variable amounts of DOPC, POPG, and POPE. DOPC and POPE
have a zwitterionic head group, whereas POPG has an anionic charged head
group. These studies showed binding affinity had a dramatic dependence on
lipid composition. The effect of pH on peptide binding and behavior was also
examined and, as expected, also impacted binding affinity. Quenching of the
Trp fluorescence by acrylamide was performed to confirm that the Trp was
located in the membrane. Likewise circular dichroism (CD) spectroscopy
was used to determine the structure of the peptide upon interaction with the
lipid vesicles. Additionally, in an assay monitoring membrane permeabilization
of E. coli the C18G Y3WK R peptide was shown to permealize bacterial mem-
branes in a concentration dependent manner.
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Antimicrobial peptides have gained interest as potential anti-cancer agents, e.g.
inhibition of tumour growth in human prostate xenografts was shown by host
defense like lytic peptides (1). We showed by Annexin V binding that, in pros-
tate tumour cells, negatively charged phosphatidylserine (PS) accumulates inthe outer plasma membrane leaflet, which normally resides in the inner leaflet.
Thus, surface exposure of PS may make these cells susceptible to killing by
these cationic peptides.
The aim of this study is to develop short peptide sequences derived from NK-2,
which was shown to have anti-tumour activity (2). NKCS (Cys of NK-2
exchanged by Ser) is composed of two a-helices connected with a hinge region.
Initially we studied the interaction of the parent peptide and its N- and C-
terminal part with membrane mimetic systems. Vesicle leakage experiments
revealed that the N-terminal fragment exhibits similar affinity towards PS as
NKCS. Thermodynamic experiments indicate that the N-terminal helix resem-
bles the properties of NKCS. Furthermore, calorimetric studies revealed that
NKCS and its fragments have no significant effect on the thermotropic behav-
iour of PC liposomes mimicking healthy mammalian cell membranes. Both
circular dichroism and Monte-Carlo simulation using the bilayer parameters
derived from our structural characterization of the lipid model systems showed
that the selectivity for PS correlated with the alpha-helical content of the
peptides. The C-terminal part was less structured showing lower affinity to
PS containing membranes. Thus, the shorter N-terminal peptide can be used
as a template for further optimization, as in vitro tests on a human prostate
carcinoma cell line showed significant cell damage.
(1) Papo N. et al., Cancer Res. 66 (2006) 5371-8.
(2) Schro¨der-Borm H. et al., FEBS Lett. 579 (2005) 6128-61.
Acknowledgement: EC - Marie-Curie Action: BIOCONTROL (MCRTN -
33439)
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Recently, antimicrobial peptides (AMPs) have emerged as a promising antican-
cer remedy. Negative charge of the bacterial membranes gives some measure
for selectivity of cationic AMPs, since mammalian cell membranes are largely
zwitterionic. Accumulating evidence indicates that lipid composition of the
cancer cell membranes is different from a healthy cell, displaying net mem-
brane surface negative charge. Understanding the nature of the negatively
charged membrane domains could provide a new basis for anticancer therapy
drug design using antimicrobial peptides or their synthetic mimics. Here, we
examine the effect of membrane glycosylation, which is shown to be increased
in cancer cells, on activity of AMP analogs. In this work we probe interactions
of antimicrobial peptide mimic, based on acyl-lysine architecture (OAK), C12
K-7a8, with Langmuir monolayers containing monosialoganglioside GM3 and
disialoganglioside GD3. Langmuir isotherms and fluorescence microscopy
imaging results of pure GM3 and GD3 monolayers indicate a single liquid-
extended (LE) phase. Constant pressure insertion assays show significant
insertion of C12 K-7a8 in both GM3 and GD3 monolayers at 30mN/m. AMP
analogue insertion was also observed for GM3: DPPC (30:70) and GD3: DPPC
(30:70) mixed monolayers, however at smaller extent as expected. Synchrotron
grazing Incidence X-Ray diffraction (GIXD) data show a disordered phase for
GD3 and a weak ordering for GM3, which disappears immediately after intro-
duction of the AMP. X-ray Reflectivity data indicate the thinning of the lipid
layer upon peptide insertion.
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We wish to use the pH-(Low)-Insertion-Peptide (pHLIP) to transport therapeu-
tic agents to acidic tumors, with the ultimate goal of improving the treatment
of cancer. pHLIP inserts into a lipid bilayer under slightly acidic conditions
(pH 6-6.5), forming a transmembrane helix. We demonstrate here that pHLIP-
mediated translocation of a cell-impermeable, polar toxin phalloidin can inhibit
the proliferation of cancer cells. The delivery constructs, pHLIP-K(rho)C(aph)
and pHLIP-C(aph), both carry the phalloidin toxin at the inserting C-terminus,
via a disulfide linkage that could be cleaved in cells. The constructs differ in that
a lipophilic rhodamine moiety is also attached to the inserting end, near the
phalloidin cargo, in pHLIP-K(rho)C(aph). After a brief incubation with
2-4 mMof pHLIP-K(rho)C(aph) at pH 6.1-6.2 (for 1-3 h), proliferation of HeLa,
JC, and M4A4 cancer cells were severely disrupted (> 90% inhibitions). Cells
